These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38057883)

  • 1. Inter-rater reliability of risk of bias tools for non-randomized studies.
    Kalaycioglu I; Rioux B; Briard JN; Nehme A; Touma L; Dansereau B; Veilleux-Carpentier A; Keezer MR
    Syst Rev; 2023 Dec; 12(1):227. PubMed ID: 38057883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessor burden, inter-rater agreement and user experience of the RoB-SPEO tool for assessing risk of bias in studies estimating prevalence of exposure to occupational risk factors: An analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
    Momen NC; Streicher KN; da Silva DTC; Descatha A; Frings-Dresen MHW; Gagliardi D; Godderis L; Loney T; Mandrioli D; Modenese A; Morgan RL; Pachito D; Scheepers PTJ; Sgargi D; Paulo MS; Schlünssen V; Sembajwe G; Sørensen K; Teixeira LR; Tenkate T; Pega F
    Environ Int; 2022 Jan; 158():107005. PubMed ID: 34991265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-rater reliability and validity of risk of bias instrument for non-randomized studies of exposures: a study protocol.
    Jeyaraman MM; Al-Yousif N; Robson RC; Copstein L; Balijepalli C; Hofer K; Fazeli MS; Ansari MT; Tricco AC; Rabbani R; Abou-Setta AM
    Syst Rev; 2020 Feb; 9(1):32. PubMed ID: 32051035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-Rater Agreement in Assessing Risk of Bias in Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST): Results from a Controlled Experiment on the Effect of Specific Rater Training.
    Kaiser I; Pfahlberg AB; Mathes S; Uter W; Diehl K; Steeb T; Heppt MV; Gefeller O
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RoB-SPEO: A tool for assessing risk of bias in studies estimating the prevalence of exposure to occupational risk factors from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
    Pega F; Norris SL; Backes C; Bero LA; Descatha A; Gagliardi D; Godderis L; Loney T; Modenese A; Morgan RL; Pachito D; Paulo MBS; Scheepers PTJ; Schlünssen V; Sgargi D; Silbergeld EK; Sørensen K; Sutton P; Tenkate T; Torreão Corrêa da Silva D; Ujita Y; van Deventer E; Woodruff TJ; Mandrioli D
    Environ Int; 2020 Feb; 135():105039. PubMed ID: 31864023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-rater reliability and concurrent validity of ROBINS-I: protocol for a cross-sectional study.
    Jeyaraman MM; Rabbani R; Al-Yousif N; Robson RC; Copstein L; Xia J; Pollock M; Mansour S; Ansari MT; Tricco AC; Abou-Setta AM
    Syst Rev; 2020 Jan; 9(1):12. PubMed ID: 31931871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application.
    Minozzi S; Cinquini M; Gianola S; Gonzalez-Lorenzo M; Banzi R
    J Clin Epidemiol; 2020 Oct; 126():37-44. PubMed ID: 32562833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodologically rigorous risk of bias tools for nonrandomized studies had low reliability and high evaluator burden.
    Jeyaraman MM; Rabbani R; Copstein L; Robson RC; Al-Yousif N; Pollock M; Xia J; Balijepalli C; Hofer K; Mansour S; Fazeli MS; Ansari MT; Tricco AC; Abou-Setta AM
    J Clin Epidemiol; 2020 Dec; 128():140-147. PubMed ID: 32987166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting Risk of Bias Tools for Observational Studies for a Systematic Review of Anthropometric Measurements and Dental Caries among Children.
    Mamikutty R; Aly AS; Marhazlinda J
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUQUEST-NUtrition QUality Evaluation Strengthening Tools: development of tools for the evaluation of risk of bias in nutrition studies.
    Kelly SE; Greene-Finestone LS; Yetley EA; Benkhedda K; Brooks SPJ; Wells GA; MacFarlane AJ
    Am J Clin Nutr; 2022 Jan; 115(1):256-271. PubMed ID: 34605544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability.
    Banzi R; Cinquini M; Gonzalez-Lorenzo M; Pecoraro V; Capobussi M; Minozzi S
    J Clin Epidemiol; 2018 Jul; 99():24-32. PubMed ID: 29526556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials.
    Armijo-Olivo S; Ospina M; da Costa BR; Egger M; Saltaji H; Fuentes J; Ha C; Cummings GG
    PLoS One; 2014; 9(5):e96920. PubMed ID: 24824199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying the risk of bias tool in a systematic review of combination long-acting beta-agonists and inhaled corticosteroids for persistent asthma.
    Hartling L; Bond K; Vandermeer B; Seida J; Dryden DM; Rowe BH
    PLoS One; 2011 Feb; 6(2):e17242. PubMed ID: 21390219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool.
    Bilandzic A; Fitzpatrick T; Rosella L; Henry D
    PLoS Med; 2016 Apr; 13(4):e1001987. PubMed ID: 27046153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective comparison of live and video-based assessments of colonoscopy performance.
    Scaffidi MA; Grover SC; Carnahan H; Yu JJ; Yong E; Nguyen GC; Ling SC; Khanna N; Walsh CM
    Gastrointest Endosc; 2018 Mar; 87(3):766-775. PubMed ID: 28859953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-rater and intra-rater reliability of the current assessment model and tools for laparoscopic suturing.
    Wei CH; Shen SC; Duh YC; Tsai KY; Chen HA; Huang SW
    Surg Endosc; 2022 Sep; 36(9):6586-6591. PubMed ID: 35102428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring test-retest reliability (TRR) of AMSTAR provides moderate to perfect agreement - a contribution to the discussion of the importance of TRR in relation to the psychometric properties of assessment tools.
    Bühn S; Ober P; Mathes T; Wegewitz U; Jacobs A; Pieper D
    BMC Med Res Methodol; 2021 Mar; 21(1):51. PubMed ID: 33706710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Customized guidance/training improved the psychometric properties of methodologically rigorous risk of bias instruments for non-randomized studies.
    Jeyaraman MM; Robson RC; Copstein L; Al-Yousif N; Pollock M; Xia J; Balijepalli C; Hofer K; Mansour S; Fazeli MS; Ansari MT; Tricco AC; Rabbani R; Abou-Setta AM
    J Clin Epidemiol; 2021 Aug; 136():157-167. PubMed ID: 33979663
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.